— Know what they know.
Not Investment Advice

GERM

ETFMG Treatments, Testing and Advancements ETF
1W: +0.6% 1M: +3.0% 3M: -4.7% 1Y: -0.1% 3Y: -55.6%
$19.16
Last traded 2024-09-05 — delisted
ETF AMEX · AUM $9.6M
Key Statistics
AUM$10M
Holdings57
Top 10 Wt54.5%
Volume4,828
Avg Volume1,202
Beta1.02
Portfolio Fundamentals
P/E16.8
P/B0.6
Div Yield0.79%
ROE3.2%
% Profitable33%
Inception2020-06-18
Sector Allocation
Healthcare 99.3%
Financial Services 0.3%
Other 0.3%
Top 10 Holdings
# Name Ticker Weight % Market Value Shares
1 Alnylam Pharmaceuticals Inc ALNY 11.39% $1.1M 3,957
2 Labcorp Holdings Inc LH 7.20% $674,398 2,978
3 Quest Diagnostics Inc DGX 6.61% $618,442 4,142
4 BioNTech SE BNTX 5.01% $468,882 5,803
5 Bio-Rad Laboratories Inc BIO 4.74% $443,370 1,363
6 Vaxcyte Inc PCVX 4.52% $423,098 5,432
7 QuidelOrtho Corp QDEL 4.11% $384,985 9,250
8 BioCryst Pharmaceuticals Inc BCRX 3.70% $346,600 45,426
9 Immunocore Holdings PLC IMCR 3.67% $343,207 9,226
10 Zai Lab Ltd ZLAB 3.60% $337,054 20,729

Recent Holding Changes

No recent changes

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms